| scholarly article | Q13442814 |
| P50 | author | Xiangguo Qiu | Q66680131 |
| P2093 | author name string | Ke Tang | |
| Qing Chen | |||
| Xiaoyu Zhang | |||
| Wenjun Zhu | |||
| Ying Guo | |||
| Feihu Yan | |||
| Jiamei Guo | |||
| Logan Banadyga | |||
| Shihua He | |||
| P2860 | cites work | Dissection of the role of the stable signal peptide of the arenavirus envelope glycoprotein in membrane fusion | Q36023061 |
| The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset | Q36146469 | ||
| The role of proteolytic processing and the stable signal peptide in expression of the Old World arenavirus envelope glycoprotein ectodomain | Q36532761 | ||
| Lassa Virus Cell Entry via Dystroglycan Involves an Unusual Pathway of Macropinocytosis. | Q37073355 | ||
| Investigational p38 inhibitors for the treatment of chronic obstructive pulmonary disease | Q38323383 | ||
| Efficacy of Favipiravir Alone and in Combination With Ribavirin in a Lethal, Immunocompetent Mouse Model of Lassa Fever | Q38565357 | ||
| Mutational Analysis of Lassa Virus Glycoprotein Highlights Regions Required for Alpha-Dystroglycan Utilization | Q38662402 | ||
| Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds | Q38820461 | ||
| New World Arenavirus Biology. | Q39394740 | ||
| Drug Repurposing: New Treatments for Zika Virus Infection? | Q40054261 | ||
| pH-induced activation of arenavirus membrane fusion is antagonized by small-molecule inhibitors | Q40410440 | ||
| Identification of a broad-spectrum arenavirus entry inhibitor | Q40411501 | ||
| Determining Ribavirin's mechanism of action against Lassa virus infection | Q41718140 | ||
| NRP2 and CD63 Are Host Factors for Lujo Virus Cell Entry. | Q45325056 | ||
| Past, present, and future of arenavirus taxonomy | Q46734627 | ||
| Establishment of pseudovirus infection mouse models for in vivo pharmacodynamics evaluation of filovirus entry inhibitors. | Q54107807 | ||
| Current research for a vaccine against Lassa hemorrhagic fever virus | Q56909960 | ||
| Screening and Identification of Lassa Virus Entry Inhibitors from an FDA-Approved Drug Library | Q56999457 | ||
| Tangeretin, an extract from Citrus peels, blocks cellular entry of arenaviruses that cause viral hemorrhagic fever | Q58550872 | ||
| Lassa fever | Q88504090 | ||
| A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS | Q107473800 | ||
| Virus entry. Lassa virus entry requires a trigger-induced receptor switch | Q24299858 | ||
| Genetic diversity among Lassa virus strains | Q24525321 | ||
| X-ray structure of the arenavirus glycoprotein GP2 in its postfusion hairpin conformation | Q27675862 | ||
| Fusion of Enveloped Viruses in Endosomes | Q28073406 | ||
| Regulation of Muscle Stem Cell Functions: A Focus on the p38 MAPK Signaling Pathway | Q28078887 | ||
| Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus | Q28291275 | ||
| Drug repositioning: identifying and developing new uses for existing drugs | Q29614779 | ||
| A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activity | Q30279239 | ||
| Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection | Q30419612 | ||
| Analysis of Lujo virus cell entry using pseudotype vesicular stomatitis virus | Q33744103 | ||
| Arenavirus stable signal peptide is the keystone subunit for glycoprotein complex organization | Q34440915 | ||
| Arenaviruses. I. The epidemiology molecular and cell biology of arenaviruses. Introduction. | Q34622855 | ||
| A specific interaction of small molecule entry inhibitors with the envelope glycoprotein complex of the Junín hemorrhagic fever arenavirus | Q34675921 | ||
| Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs | Q35050840 | ||
| Identification and Mechanism of Action of a Novel Small-Molecule Inhibitor of Arenavirus Multiplication | Q35751585 | ||
| Cationic amphiphilic drugs cause a marked expansion of apparent lysosomal volume: implications for an intracellular distribution-based drug interaction | Q35947304 | ||
| Small-Molecule Fusion Inhibitors Bind the pH-Sensing Stable Signal Peptide-GP2 Subunit Interface of the Lassa Virus Envelope Glycoprotein | Q36021966 | ||
| P921 | main subject | Lassa virus | Q1806636 |
| P1104 | number of pages | 10 | |
| P304 | page(s) | 68-77 | |
| P577 | publication date | 2019-04-04 | |
| P1433 | published in | Antiviral Research | Q4775352 |
| P1476 | title | Identification of a clinical compound losmapimod that blocks Lassa virus entry | |
| P478 | volume | 167 |
| Q89469891 | Discovery, synthesis, and optimization of an N-alkoxy indolylacetamide against HIV-1 carrying NNRTI-resistant mutations from the Isatis indigotica root |
| Q96304535 | Identification of the dietary supplement capsaicin as an inhibitor of Lassa virus entry |
| Q94954969 | Lassa Virus Genetics |
Search more.